A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Subcutaneous Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis
Author(s):
Sieper, J.; Heijde, D. van der; Dougados, M.; Maksymowych, W.; Boice, J.; Bergman, G.; Curtis, S.; Tzontcheva, A.; Huyck, S.; Weng, H.H.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-10-31
Language
English
Is part of
Arthritis and Rheumatology (2014), Vol. 66, p. S1283-S1284
